Study Objectives: To investigate whether cognitive behavior therapy was effective for older adults with comorbid insomnia and depression in a community mental health setting, and explore whether an advanced form of cognitive behavior therapy for insomnia produced better outcomes compared to a standard form of cognitive behavior therapy for insomnia.
Introduction
Insomnia is a common sleep-wake problem among older adults with severe mental illness. Insomnia and depression share a strong bidirectional relationship [1] . Studies have reported that up to 70% of older adults with depression can experience comorbid insomnia symptoms [2, 3] . Researchers have established that insomnia often plays a significant role in precipitating and perpetuating depressive symptoms [4] [5] [6] . Although most older adults with depression experience difficulties initiating or maintaining sleep, insomnia is often discounted as a specific target for treatment [7] . When comorbid insomnia is not adequately assessed or treated, a greater risk of depressive relapse and suicide is possible [8, 9] . The association between insomnia and depression not only has the potential to cause life-threatening consequences, but also presents significant direct and indirect costs to the wider healthcare system [10] . Since mental health services have limited budgets and stretched resources, an efficient approach is to target highly prevalent comorbid conditions with innovative evidence-based treatments.
A compelling literature base has emerged over the past 30 years highlighting the positive effects of cognitive behavior therapy for insomnia (CBT-I). This treatment program offers several practical skills to help change unhelpful cognitive and behavioral patterns that exacerbate insomnia [11] [12] [13] . Metaanalyses have shown CBT-I to be an effective and first-line treatment option for insomnia disorder [14] [15] [16] . CBT-I compares favorably against pharmacotherapy treatments and produces longer lasting positive effects [17] [18] [19] [20] . Historically CBT-I research focused on primary insomnia and excluded people with comorbidities; however, a growing body of research has now established that CBT-I is also efficacious for comorbid insomnia [21] [22] [23] . Despite these important research developments, CBT-I trials have been primarily based on younger or middle-aged adults (mean age below 65 years). As a result, older adults (mean age above 65 years) with comorbid severe mental illnesses have been under-represented in the CBT-I literature.
Currently, it is unknown whether CBT-I is effective for older adults who are receiving outpatient aged persons mental health services. This is an essential group to include in clinical research because the older adult population is growing rapidly [24] , which will inevitably place greater demands mental health practitioners [25] . From a CBT-I "stepped care" framework [26] , the needs of this aged cohort likely meet the middle to top tiers of CBT-I service delivery. Older adults who require community mental health services typically present with heterogeneous biopsychosocial formulations and tend to have severe, recurrent/persistent, and multiple interrelated comorbidities [25, 27] . A randomized controlled trial (RCT) is needed within this setting because promising evidence indicates CBT-I not only improves insomnia but has the potential to also reduce depression.
Recent RCTs suggest CBT-I reduces both insomnia and depression severity (for review see ref. [28] ). Two recent innovative studies have come from Blom et al. [29] and Norell-Clarke et al. [30] . Both of these trials were based in Sweden and included middle-aged adults with comorbid insomnia and depression. Blom et al. tested two internet-based CBT programs over the course of 9 weeks (N = 43, M age = 47 years). One condition focused on treating insomnia (iCBT-I) and the other focused on treating depression (iCBT-D). Blom et al. found iCBT-I was more effective at reducing insomnia severity (Cohen's d = 1.06) compared to iCBT-D (Cohen's d = 0.54), and reported both conditions were equally as effective at reducing depressive symptoms (iCBT-I Cohen's d = 0.74; iCBT-D Cohen's d = 0.66). Notable weaknesses in Blom et al.' s trial were the absence of a control condition, modest sample size, and the study was not blinded. Another important consideration was Blom et al.'s participants were able to self-refer and engage independently in an internet-based self-help program. This means that people with low computer literacy and complex comorbidities will unlikely engage in this form of treatment [26, 28] . Therefore, traditional face-to-face modes of therapy remain a central CBT-I option. Norell-Clarke et al. [30] . compared a group-based CBT-I program with a relaxation control group over four biweekly sessions (N = 64, M age = 51 years). Norell-Clarke et al. found CBT-I was more effective than relaxation in reducing insomnia severity (CBT-I Cohen's d = 2.02, relaxation Cohen's d = 1.28), whereas both conditions had similar but less effects on reducing depression severity (CBT-I d = 0.76, relaxation d = 0.26). Despite the small yet emerging base of research that has found CBT-I to have a positive impact on comorbid insomnia and depression, recent studies have reported some discrepancies in results. For instance, the recent Carney et al. [31] trial did not find differential improvement in insomnia severity among conditions, and it is not clear that it found differential improvement on depression levels as each condition showed similar improvements. Manber et al. [32] also found no differential improvement of CBT-I plus antidepressants on depression severity or remission relative to a control group in a large heterogeneous sample, thus failing to replicate their earlier pilot results. These inconsistent findings create an opportunity to advance treatment by considering whether a modified form of CBT-I that includes additional mood-enhancing strategies could strengthen outcomes.
Researchers have recently proposed a hybrid form of CBT that simultaneously treats comorbid insomnia and depression may produce better outcomes [33] [34] [35] [36] . "Advanced" CBT-I includes additional therapeutic content designed to reduce both insomnia and depression within the one multicomponent program [27, 28] . "Standard" CBT-I, on the other hand, limits its focus to treating insomnia [27, 28] . Since insomnia and depression are strongly intertwined and can aggravate each other, researchers have suggested a logical step to test whether proactively addressing both problems produce stronger results [27, 28] . Cognitive behavior therapy for insomnia plus positive mood strategies (CBT-I+) combines well-proven CBT strategies for depression (e.g. behavioral activation, cognitive reframing for depression, and hopeful affirmations) with established CBT-I interventions (e.g. stimulus control, sleep restriction, sleep hygiene, relaxation, cognitive reframing for insomnia). Although is it currently unknown whether advanced CBT-I+ produces better outcomes than standard CBT-I, Lichstein and colleagues [36] recently published pilot data that suggested a telehealth mode of CBT that combined interventions for insomnia and depression may be effective for older adults with co-occurring insomnia and depression. Five participants (M age 65 years) from remote parts of Alabama, United States, completed 10 weekly sessions of CBT for insomnia and depression via Skype in their primary care setting. Lichstein et al. reported the participants experienced significant reductions on both insomnia and depression severity from pre to post, which were maintained at a 2-month follow-up. Large post effect sizes were also found for insomnia (Cohen's d = 1.64) and depression (Cohen's d = 1.14). Lichstein et al.'s small pilot study provides a platform to test whether advanced CBT-I+ improves insomnia and depression more than standard CBT-I. The implications from a well-designed RCT could influence the future direction of CBT-I program development and delivery.
The primary aim of this study involved investigating whether CBT-I was an effective treatment for older adults with comorbid insomnia and depression within a community mental health setting. It was hypothesized that CBT-I would generate greater reductions in insomnia and depression severity than a psychoeducation control post-treatment. A second aim was to explore whether an advanced form of CBT-I+ produced better outcomes compared to a standard CBT-I program. It was anticipated that CBT-I+ would have larger reductions in insomnia and depression severity compared to CBT-I post-treatment.
Methods

Participants and recruitment
This RCT was open to older adults who had been referred to or were case managed by an aged persons' community mental health service in regional parts of Victoria, Australia. Ethics approval was granted by Federation University Australia, Latrobe Regional Hospital, and Peninsula Health Human Research Ethics Committees. Recruitment was conducted between 2014 and 2016 via telephone or face-to-face by mental health clinicians (e.g. psychologists, psychiatric nurses, social workers, occupational therapists, psychiatrists). An inclusive approach was adopted in this trial to capture the heterogeneous nature of older adults who require involvement from community-based mental health services. Interested participants who provided consent underwent a face-to-face assessment process at their home or an outpatient mental health clinic. The multi-dimensional assessment process involved conducting a clinical interview, administering and collecting a questionnaire package and sleep diary. Figure 1 illustrates the participants' pathway throughout the trial.
Participants were eligible if they met the following criteria:
(1) Aged 65 years old or above, Disorders (5th edition, DSM-V) criteria for insomnia disorder (with comorbidity) and major depressive disorder [37] .
The following exclusion criteria were applied:
(1) Did not meet criteria for comorbid insomnia and major depression [37] 
Diagnosis
A two-step assessment process was implemented to diagnose the presence of insomnia disorder with comorbidity and major depressive disorder [37] .
Step 
Randomization
A block/cluster randomization design was implemented to randomly allocate each eligible participant to one of three conditions (CBT-I; CBT-I+; PCG). The random group allocations were generated by an independent senior statistician at Federation University Australia. Although the participants were informed the trial was testing different forms of CBT, participants were blinded to the study's hypotheses and condition they had been randomly allocated to complete. More details on the randomization process are available in Sadler et al. [27] .
Outcome measures
Outcome measures were completed on three occasions throughout the RCT, at pre-treatment (week 0), post-treatment (week 8), and 3-month follow-up (week 20). Eligible participants were given a voucher (AUS$20) each time they completed the outcome measures (pre, post, follow-up) to acknowledge their time and commitment during the trial.
Primary measures
Since insomnia and depression were conceptualized as being comorbid conditions in this trial, two primary measures were applied, the ISI [42] and the GDS [43] . The ISI is a seven-item selfreport measure of insomnia severity commonly used in research with older adults [16, 19] . It possesses acceptable psychometric properties and is sensitive to treatment response [44] . The GDS is a 30-item reliable and valid measure that assesses and detects changes in depression severity for older adults [43] . A full description of the primary and secondary measures for this trial can be found in Sadler et al. [27] .
Secondary measures
The consensus sleep diary (CDS) [45] was completed by participants at each assessment point. SOL, WASO, total sleep time (TST), SE, and sleep quality (SQ) were calculated from the sleep diary data. The sleep diary was completed over a 1-week period, instead of the recommended 2 weeks, to increase compliance and reduce a possible attention placebo effect for insomnia. The sleep diary was used as a secondary outcome instead of a primary outcome because there was no equivalent measure for assessing depression [29] . Additional secondary measures included the Dysfunctional Beliefs and Attitudes About Sleep 10-item Scale (DBAS-10) [46] , SLEEP-50 Scale [47] , Geriatric Anxiety Inventory-Short Form (GAI-SF) [48] , Beck Hopelessness Scale (BHS) [49] , and The EuroQol 5-D 3-L Scale (EQ-5D-3L) [50] .
Assessors and therapists
The assessors and therapists (n = 10) were registered provisional and generalist psychologists who were undertaking a gero-psychology post-graduate clinical placement within a community mental health service. Each assessor and therapist commenced the placement with at least 12 months of theoretical and practical training in assessing psychopathology and implementing CBT. They each received training and daily supervision throughout their placement in (1) assessing and conceptualizing psychogeriatric comorbid insomnia and depression, (2) administering and interpreting the assessments/outcome measures, and (3) [26] guidelines. Clinical supervision sessions were provided by the first author (P.S.), who is a senior clinical psychologist and is experienced in delivering CBT to older adults with comorbid insomnia and depression. Therapist protocol adherence was closely monitored by the clinical supervisor via group supervision meetings, audio recordings, and written materials (e.g. protocol session checklist, homework tasks). The groups were delivered by co-therapists. The co-therapists delivered between two to three groups during their placement. The therapists were aware of the study's hypotheses and differences between conditions. Each assessor and therapist had opportunities to perform both roles throughout their placement. The post and follow-up assessors were blinded to the condition the participant had completed. The therapists did not conduct post or follow-up assessments on participants they had treated.
Interventions
Standard CBT-I is a well-established time-limited multicomponent treatment program that includes a combination of educational, cognitive, and behavioral interventions [11] [12] [13] . CBT-I aims to improve sleep by correcting dysfunctional cognitive and behavioral patterns that perpetuate insomnia [52] [53] [54] . Participants who received CBT-I attended eight, weekly, 60-to 90-minute sessions, which included small groups of five or six participants. A small group-based mode of therapy was chosen to increase the participants' sense of connectedness and present opportunities for socialization [30] . Larger group sizes were not offered due to the severity and complexity of the participants' psychopathology. Two therapists co-facilitated the groups, which assisted in crosschecking treatment protocols, managing clinical risks, and increasing group cohesiveness.
The standard CBT-I program considered guidelines from experts in the field of treating late-life comorbid insomnia [11, 13, 19, 54] . The session format and treatment delivery followed a focused CBT structure [54] [55] [56] . Therapy worksheets and homework activities were reviewed each week and kept in the participant therapeutic workbooks. The behavioral modification interventions were provided in the first four sessions, these included stimulus control (e.g. go to bed only when sleepy), sleep restriction (e.g. initially limit time spent in bed to increase SE), sleep hygiene (e.g. remove stimulating sources from the bedroom, such as television/radio/clock), and relaxation (e.g. diaphragmatic breathing, guided imagery). Cognitive restructuring of unhelpful sleep beliefs (e.g. thought diaries, behavioral experiments) and relapse prevention (e.g. summary of effective skills, maintaining progress) were implemented in the latter half of the program. For a more detailed description of the experiential conditions tested in this RCT, see Sadler et al. [27, 28] .
Advanced
The advanced CBT-I+ program was identical to the standard CBT-I program, but included three additional CBT strategies that specifically targeted comorbid depression [27, 28] . The first additional technique involved behavioral activation (e.g. daily positive activity scheduling). This task was practiced during sessions 3 and 4, and was reinforced consistently throughout the rest of the program. The second strategy involved cognitive reframing for depression. This involved practicing additional cognitive restructuring exercises (thought diaries) during sessions 6 and 7 to address negative thoughts that exacerbated depressed mood. Finally, positive affirmations designed to increase hopefulness (positive data logs and cue cards) were practiced during sessions 7 and 8. The advanced CBT-I+ sessions ran for approximately 75-90 minutes due to the additional therapeutic content, whereas the standard CBT-I sessions were generally shorter in length (e.g. 60-75 minutes).
Control
Participants randomly assigned to the psychoeducation control group (PCG) also attended eight weekly group-based sessions. The therapeutic content in PCG was substantially different from the treatment groups because PCG only included psychoeducation about sleep, insomnia, and depression, and omitted the active cognitive or behavioral change strategies designed to change cycles of insomnia and depression [27] . Furthermore, there were no prescribed homework or relapse prevention exercises. Although PCG contained a similar session structure to the experiential conditions, PCG involved a more supportive counseling approach. For instance, PCG therapists were instructed to reflect and validate the participants' thoughts and feelings, but allow the participants' to continue their line of conversation. The CBT-I and CBT-I+ therapists were trained to clarify the participants' thoughts and feelings, and utilize CBT techniques (e.g. Socratic questioning, reframing, goal setting, reinforcement, problem-solving) to redirect the conversation back onto practicing the applicable CBT strategy. PCG was considered an active control group as it controlled for nonspecific confounding treatment effects (e.g. therapeutic alliance) [30] .
Therapeutic process considerations
Data from the assessment interviews were reviewed during clinical supervision meetings to construct biopsychosocial insomnia and depression case conceptualizations. In recognition of the increased challenges that older adults can experience during therapy [57] [58] [59] , several "process-orientated" strategies were implemented across all conditions to increase therapeutic engagement, adherence, and retention. First, brief breaks were conducted during each therapy session to manage participant fatigue and offer opportunities to model in situ behavior experiments (e.g. techniques to reduce naps). Second, organizing transport to participate was an initial barrier for some participants. Therefore, considerable time was devoted to problem-solving transport options to confirm their weekly attendance. Third, initial telephone reminders were made by therapists to offer encouragement and motivation to attend. Fourth, a "caring card" was posted to participants if they missed a session, which also included the relevant session information/tasks they had missed. The "caring cards" were signed by the group participants and stated, "Thinking of you. We look forward to seeing you at our next meeting to continue working through the program." Fifth, each participant was encouraged to nominate a support person (e.g. spouse, child, friend, case manager) to consolidate the weekly session materials. Nominating a support person was completed during the first session of each condition and was regularly reviewed throughout therapy. The role of the support person was to assist the participant with homework application (e.g. reviewing worksheets, implementing strategies) and with weekly session attendance (e.g. providing transport). The support person did not have direct contact with the study (e.g. not present during group sessions). Finally, the therapeutic workbooks with weekly worksheet activities were specifically designed for older adults. For instance, the material was written in larger font with case example activities more applicable to older adults. These processorientated strategies are discussed further in Sadler et al. [28] .
Statistical analyses
Data were entered, screened, and analyzed using SPSS Version 24. Baseline demographics were calculated with frequency/descriptive analyses and further explored using t-tests/Chi-square tests. Quantitative primary and secondary variables were analyzed using linear mixed modeling (LMM). LMM enabled testing for the presence of cluster effects due to the group mode of clinical program delivery, and for intra-subject random effects, or equivalently correlation of participants' measures over time. There was no significant evidence of group cluster effects. The best fitting correlation structure was compound symmetry (exchangeable correlation), meaning constant correlation of each participants' measures over the three time points. The LMM models incorporated differences between the three intervention conditions, longitudinal trends over time, and group-time interactions.
A number of dichotomous variables (e.g. diagnosis) were analyzed using longitudinal logistic regression fitted by the method of generalized estimating equations (GEE). Again, the best fitting intra-subject correlation structure was exchangeable correlation. In some cases, longitudinal logistic regression was not possible because of "non-structural zeros" (e.g. empty cells in the cross-tabulations of diagnosis by time-point due to 0% or 100% of cases having a diagnosis at a particular time). When all participants had the diagnosis at baseline, equality of proportions diagnosed in the three intervention conditions were tested at post and follow-up, using Chi-square tests of independence.
Effect sizes (Cohen's d) were calculated by dividing the mean difference by the square root of the residual variance of each measure and condition. Power analysis details for this trial are presented in Sadler et al. [27] .
Results
Baseline characteristics
No significant differences between the three conditions (CBT-I, CBT-I+, PCG) were detected at baseline for demographic variables ( 
Primary outcomes
Results for the primary outcome variables are shown in Table 3 and Figures 2 and 3 . The CBT-I and CBT-I+ conditions both had significant reductions in insomnia severity (as measured by the ISI) from pre to post (p < .001), which were maintained at follow-up. The PCG condition did not have a significant reduction in insomnia severity from pre to post (p = .144). CBT-I generated significantly greater reductions in insomnia severity than PCG from pre to post (p < .001). This was also found when comparing CBT-I+ and PCG for insomnia severity from pre to post (p < .001).
Outcomes were similar for depression severity (as measured by the GDS), with both CBT-I and CBT-I+ having significant reductions in depression severity from pre to post (p < .001) that were maintained at follow-up. The PCG condition had no significant changes in GDS scores from pre to post (p = .153). CBT-I and CBT-I+ both had significantly greater reductions in depression severity than PCG from pre to post (p < .001).
The CBT-I and CBT-I+ conditions were not significantly different at reducing insomnia or depression severity at post or follow-up. Large effect sizes were found for both CBT-I and CBT-I+ on insomnia and depression severity at post and follow-up. 
Remission rates
Insomnia disorder and major depressive disorder were assessed at each assessment point (pre, post, follow-up) using DSM-V criteria [37] . Participants were categorized into dichotomous variables (yes or no) as either having the diagnosis or not. The same multidimensional assessment process that was conducted during the preliminary eligibility assessment was also conducted at post and follow-up.
In the CBT-I condition, 71% (17 of 24) no longer met DSM-V criteria for comorbid insomnia at post, which was maintained at follow-up (68%). Similarly, 78% (18 of 23) who completed CBT-I+ no longer had comorbid insomnia at post; however, this remission rate reduced to 45% at follow-up. The PCG condition demonstrated 27% (6 of 22) no longer had comorbid insomnia at post and 14% at follow-up.
Eighty-eight percent (21 of 24) of participants who completed CBT-I and 78% (18 of 23) who completed CBT-I+ no longer met DSM-V criteria for major depression at post. Follow-up remission rates were 73% for CBT-I, and 64% for CBT-I+. In the PCG condition, 36% (8 of 22) no longer met depression criteria at post, and 19% at follow-up. Table 4 shows results for the secondary measures. There were significant improvements across each of the sleep diary parameters (SOL, WASO, TST, SE, SQ) for both CBT-I and CBT-I+ from pre to post (p < .001). The PCG condition did not show significant improvements in SOL, WASO, or TST from pre to post (p > .05); however, there were significant improvements observed for PCG on SE (p = .041) and SQ (p < .001) from pre to post. No significant changes were found from post to follow-up for the sleep diary metrics across conditions. No significant differences were found between the CBT-I and CBT-I+ conditions for the secondary outcomes. CBT-I and CBT-I+ each demonstrated significant improvements from pre to post for anxiety (p < .001), hopelessness (p < .001), dysfunctional beliefs about sleep (p < .001), and physical health (p < .004), which were all maintained at follow-up. For anxiety and physical health, the PCG did not show significant improvements from pre to post (p > .05); however, PCG did reveal significant improvements from pre to post for hopelessness (p = .009) and dysfunctional beliefs about sleep (p = .05) that were each maintained at follow-up.
Secondary outcomes
Discussion
This study had two primary aims. The first involved examining whether CBT-I was effective for older adults with comorbid insomnia and depression within a community mental health setting. The second aim explored whether an advanced form of CBT-I+ generated better outcomes compared to standard CBT-I. As expected, CBT-I produced significantly greater reductions in insomnia and depression severity compared to the control group that were maintained at follow-up. The second hypothesis was not supported because the advanced and standard conditions showed similar reductions in insomnia and depression severity at post and follow-up; however, the study was not sufficiently powered to conclusively test this hypothesis.
The findings from this study add to a growing body of literature that suggests CBT-I is an effective treatment for comorbid insomnia [15, 22, 30] . These results are meaningful because comorbid insomnia is highly prevalent among older adults but is often misunderstood and inadequately treated [28, 54] . This can result in poorer clinical outcomes and costly economic consequences [8] [9] [10] . The present study is the first RCT to include a highly diverse clinical sample of older adults with comorbid insomnia and depression. Previous CBT-I trials have focused on younger or middle-aged adults and have often excluded older adults with complicated comorbidities [28] . Consequently, the results from this trial demonstrate that CBT-I can significantly benefit heterogeneous psychogeriatric populations presenting with comorbid insomnia and depression. Recent RCTs have also indicated that CBT-I could have a positive effect onto comorbid depression for individuals with both conditions [29] [30] [31] . This RCT supported this proposition, as CBT-I generated significant reductions in depression severity with sustained large effect sizes at post and follow-up. This suggests that when insomnia and depression are comorbid, specifically targeting insomnia with CBT-I has an effect onto depression recovery [33] [34] [35] [36] . One of the reasons CBT-I could have a positive influence on depression is due to the transferable cognitive and behavioral mechanisms that underpin change during treatment.
There are several possible reasons why reducing insomnia severity through CBT-I could improve comorbid depression. For instance, older adults tend to experience more nighttime awakenings and are generally lighter sleepers compared to younger adults [1] [2] [3] . Hence increased early morning awakenings can result in less opportunities for deeper sleep (e.g. rapid eye movements). This means that effectively applying stimulus control (e.g. going to bed later) could increase SQ and associated energy levels [11] . Another possible mechanism of change could be increasing time-out-of-bed through sleep restriction [52, 56] . Improving the rest-activity ratio could have a mild behavioral activation effect, therefore increasing the likelihood of exposure to additional reinforcers (e.g. morning light, physical activity, socialization). Researchers have also theorized that insomnia can influence depression via endorsing negative thoughts, such as "I don't get enough sleep," "I should try harder to sleep," and "My sleep will never improve" [1, 6] . Unhelpful sleep-related beliefs have been associated with maladaptive safety behaviors (e.g. daytime napping, staying awake in bed) and physiological complaints (e.g. tension, fatigue) [61] [62] [63] . The increased desire to withdraw from daily activities could increase the individual's attempts to sleep, which in turn, could exacerbate psychophysiological arousal and reduce SE [61] [62] [63] . Cycles of negative thinking and behavioral withdrawal could further increase levels of amotivation and hopelessness, perpetuating a state of depressed mood [4, 6, 64] . This broad spectrum of cognitive and behavioral mechanisms highlight why making changes through CBT-I could transfer onto improvements in mood and function.
It was anticipated in this trial that specifically targeting depression by adding therapeutic content to CBT-I would boost overall outcomes for older adults with comorbid insomnia and depression. CBT-I+ is based on the "less of more" treatment principal, whereas CBT-I works from the "more of less" approach to treatment [28] . This means CBT-I+ offers more therapeutic material to target two interrelated problems (insomnia and depression) simultaneously within the one program, whereas CBT-I is more concentrated because it is designed to target one problem (insomnia) with a set of focused sleep strategies. Although the advanced program showed significant improvements across the primary and secondary measures, the results were similar to the standard program. In addition, although the effect sizes were consistently smaller for CBT-I+ compared to CBT-I, the study was not sufficiently powered to test for equivalence. Nevertheless, these results suggest that further refinement of CBT-I+ may be needed in future studies that test for either superiority or equivalence.
A possible reason why CBT-I+ might not be more effective than CBT-I could be the added level of complexity involved in delivering CBT-I+. The advanced program was likely more complicated to complete for both therapists and participants because of the additional theoretical and therapeutic content to practice within eight sessions. Standard CBT-I, on the other hand, may have presented a simpler form of treatment because CBT-I involved learning fewer strategies and processes compared to CBT-I+. It is suggested that a longer course of therapy (e.g. 12-16 sessions) and a more specialized training package may be required to strengthen the effect of CBT-I+. Since therapeutic adherence was not psychometrically evaluated in this study, a future project that quantitatively compares adherence between the two arms would be worthwhile to test the hypothesis that a simpler treatment (e.g. standard CBT-I) may be better suited to older adults with comorbid depression. Furthermore, a qualitative study that explores the experiences of older adults who have participated in CBT-I and CBT-I+ may also help researchers tailor more individualized treatment programs.
Research that identifies which specific CBT strategies are best suited to older adults with comorbid insomnia and depression will likely contribute significantly to improving the application of CBT-I [28] . For instance, it is anticipated that comorbid insomnia populations with greater heterogeneity and severity (e.g. psychogeriatric settings) may benefit from a more focused, simplified, and repetitious form of CBT-I. Conversely, insomnia populations that are more homogeneous (e.g. academic settings) may gain greater benefit from modified CBT-I programs that offer a greater range of strategies. Furthermore, traditional faceto-face modes of CBT-I (e.g. group, individual) will likely remain a central treatment option in geriatric clinical settings, as older adults with low computer literacy and severe comorbidities will unlikely engage in self-directed digital forms of treatment [28] . Future studies that expand these program design and delivery ideas among various comorbid insomnia populations will provide an important step in the evolution of CBT-I.
The results from this trial have important implications for community mental health services. Currently, therapists and mental health clinicians receive minimal training towards accurately assessing and conceptualizing comorbid sleep-wake disorders [26, 51, 54] . In addition, few practitioners are qualified to deliver CBT-I within clinical settings [51] . The inadequate dissemination of CBT-I has been well publicized and a series of solutions have been recommended by experts in the field [29, 51, 65] . For instance, CBT-I training packages could be delivered across disciplines to non-sleep specialists, and ongoing peer-to-peer supervision could be offered to practitioners who are interested in behavioral sleep medicine [51] . Another cost-effective option could be recruiting provisional psychologists on clinical training placements within mental health services to deliver group-based CBT-I on a continuing basis. This study highlights how relatively inexperienced mental health clinicians can be easily trained to delivery CBT-I and expect large positive effects within a complex clinical setting.
Mental health services which implement CBT-I programs will be delivering a cost-effective intervention that supports person-centered recovery principals.
It is worth noting the weaknesses and strengths of this RCT. The limitations involved (1) not employing objective biological measures, such as actigraphy or polysomnography, to validate the self-reported sleep measures, (2) the initial target sample size (as discussed in Sadler et al. [27] ) was not achieved in this trial due to timing and resource restraints, resulting in insufficient power to detect possible outcome differences between CBT-I and CBT-I+, (3) having a limited 3-month follow-up period, (4) not including CBT for depression as another comparison condition, and (5) amending diagnostic assessment tools to correlate with updated DSM-V criteria. Also, the CSD measure may have demonstrated questionable reliability because of the 1 week recording period (instead of the recommended 2 weeks). Furthermore, although all co-therapists were at a similar level of clinical experience and received the same training/supervision from the first author (P.S.), there was a chance the quality of the therapist dyad could have influenced outcomes. Finally, a validated adverse events metric was not utilized in this trial; however, participant wellbeing was closely monitored through a combination of feedback sources (e.g. participants, assessors, therapists, mental health clinicians). No complaints or critical incidents were recorded throughout this RCT, supporting the safe qualities of CBT. It is suggested that a qualitative participant feedback study would be valuable to inform future research of the potential covert limitations involved in delivering CBT-I for older adults.
The notable weaknesses within this trial were offset by its methodological and clinical strengths. This RCT built on previous research by applying DSM-V criteria and including two experiential conditions with an active comparison control. The post and follow-up assessors were blinded and the study demonstrated a high retention/completion rate. From a clinical formulation and treatment application perspective, this study provides new evidence that suggests CBT-I and CBT-I+ are beneficial for older adults with interrelated complex comorbidities. Replication of this study is necessary with a larger sample size to conclusively establish whether or not the two interventions have different or equivalent effects. Mental health services that offer and deliver treatment for insomnia with CBT will be providing evidence-based best practice for older adults with comorbid insomnia and depression.
